iNOS/NO is required for IRF1 activation in response to liver ischemia-reperfusion in mice.
Qiang DuJing LuoMu-Qing YangQuan LiuCaroline HeresYi-He YanDonna StolzDavid A GellerPublished in: Molecular medicine (Cambridge, Mass.) (2020)
This study demonstrates a novel mechanism that iNOS/NO is required for IRF1/PUMA signaling through a positive-feedback loop between iNOS and IRF1, in which HDAC2-mediated histone modification is involved to up-regulate IRF1 in response to I/R in mice.